Normal-sized Needles Segment has the Largest Share of Method in the Middle East & Africa Intradermal Injections Market during 2021–2028
According to our latest study on “Middle East & Africa Intradermal Injections Market Forecast to 2028 – COVID-19 Impact and Analysis – by Method, Application, and End User,” the market is projected to reach US$ 302.3 million by 2028 from US$ 139.1 million in 2021; it is expected to grow at a CAGR of 10.2% from 2021 to 2028. The report highlights trends prevailing in the market, and the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing prevalence of tuberculosis and allergic reactions along with rising acceptance of intradermal injection in cosmetic surgeries. However, injection site reactions and dossing limitations associated with intradermal injections shall restrict the market growth during the forecast period, to a noticeable extent.
The pandemic has boosted the demand for medical devices that can be used in a home care setting, however people visiting hospitals have been restricted due to the infection. The region has observed increasing numbers of patients admitted to intensive care units (ICU), a rising number of medications imposing multiple diagnostic and therapeutic challenges on stressed healthcare systems, leading to a rise in medical devices. Several companies have experienced changes of staff allocations and work hours and the implementation of stringent infection control and social distancing measures. Moreover, they face mental, physical, emotional, and financial challenges. The import of various drugs and medical devices was also impacted. However, medical industry segments, including intradermal injections, have experienced reduction in growth momentum and losses during the COVID-19 pandemic due to restricted manufacturing and supply chain facilities. Also, the increasing number of cases of chronic conditions has increased, which resulted in an increased diagnosis of tuberculosis and skin allergies. This pandemic affects the business operation of the various key players operating in the intradermal injection market in the region.
Based on method, the intradermal injections market is segmented into normal-sized needles, short needles, and without needles. In 2020, the normal-sized needles segment accounted for the largest share, short needles segment is expected to grow at the highest CAGR in the forecast period.
BD, West Pharmaceutical Services, Inc., Terumo Corporation, NanoPass, Pharmajet, Idevax, EUNSUNG GLOBAL, Crossject, Cardinal Health Inc., and Hindustan Syringes and Medical Devices Ltd are among the leading companies in the Middle East & Africa intradermal injections market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market.
The market for intradermal injections market is segmented into method, application, and end user. Based on method, the Middle East & Africa intradermal injections market is segmented into normal-sized needles, short needles, and without needles. Based on application, the intradermal injections market is segmented into tuberculin skin test, allergy test, local aesthetics, and others. Based on end user, the intradermal injections market is segmented into hospitals, diagnostic laboratories, academics and research institutes, and others. Geographically, the intradermal injections market is segmented into Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of Middle East & Africa).
Contact Us
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com